Generics - Pharmaceutical


Current filters:


Popular Filters

476 to 483 of 483 results

A lot of user fee issues in USA


2012 has only just begun, but the US Congress, the Food and Drug Administration and several health care…

BiotechnologyGenericsNorth AmericaPharmaceuticalPoliticsRegulation

US ANDAs filed for generic Beyaz, Isentress and Epivir


The US Food and Drug Administration says that Abbreviated New Drug Applications have been received by…

Anti-viralsBayerBeyazEpivirGenericsGlaxoSmithKlineIsentressMerck & CoPharmaceuticalRegulationReproductive

2011 a bumper year for Pharma, Biotech and Generics M&A


Although there were few multi-billion dollar deals, 2011 turned into a bumper year for the number of…

BiotechBiotechnologyGenericsMergers & AcquisitionsPharmaceutical

Pharmaceutical M&A deals in 2011


Details for the 129 M&A announcements recorded by The Pharma Letter are provided in the full table

BiotechGenericsMergers & AcquisitionsPharmaceutical

What lies ahead: pharma and health care trends for 2012?


In what probably comes as no surprise, many of the challenges now faced by the pharmaceutical industry…

GenericsGlobalHealthcareMarkets & MarketingPatentsPharmaceuticalPricing

Knighthood for GlaxoSmithKline’s Andrew Witty; Teva succession plan


Andrew Witty, chief executive of UK drug giant GlaxoSmithKline (LSE: GSK) has been awarded a Knighthood…

GenericsGlaxoSmithKlineManagementPharmaceuticalTeva Pharmaceutical Industries

Spanish pharma sales down 3.1% in October


Data from Spain’s Ministry of Health, Social Policy and Equality shows that, in October 2011, public…

EuropeGenericsMarkets & MarketingPharmaceuticalPricingResearch

476 to 483 of 483 results

Back to top